PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsDesflurane
Desflurane
Desflurane, Suprane (desflurane) is a small molecule pharmaceutical. Desflurane was first approved as Suprane on 1992-09-18. It is used to treat pain in the USA.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
signs and symptoms pathological conditionsD013568
psychological phenomenaD011579
musculoskeletal and neural physiological phenomenaD055687
Trade Name
FDA
EMA
Desflurane, Suprane
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Desflurane
Tradename
Company
Number
Date
Products
SUPRANEBaxterN-020118 RX1992-09-18
1 products, RLD, RS
Labels
FDA
EMA
Brand Name
Status
Last Update
desfluraneunapproved drug other2026-07-08
supraneNew Drug Application2026-07-15
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
painEFO_0003843D010146R52
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
N: Nervous system drugs
N01: Anesthetics
N01A: Anesthetics, general
N01AB: Halogenated hydrocarbons, general anesthetics
N01AB07: Desflurane
HCPCS
No data
Clinical
Clinical Trials
326 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ObesityD009765EFO_0001073E66.911
ArthritisD001168EFO_0005856M05-M1411
Anesthesia recovery periodD00076211
Delayed emergence from anesthesiaD05519111
Renal insufficiencyD051437N1911
Aortic valve stenosisD001024EFO_000026611
Vaginal diseasesD01462311
CalculiD00213711
Ureteral obstructionD01451711
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AnesthesiaD0007581112
CystoscopesD02068411
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Sleep wake disordersD012893G4711
Lung neoplasmsD008175C34.9011
Coronary artery bypassD001026EFO_000377611
DeliriumD003693R41.011
DementiaD003704EFO_0003862F0311
MorbidityD00901711
AmnesiaD000647EFO_1001454F44.011
Cognition disordersD00307211
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameDesflurane
INNdesflurane
Description
Desflurane is an organofluorine compound. It has a role as an inhalation anaesthetic. It is functionally related to a methoxyethane.
Classification
Small molecule
Drug classgeneral inhalation anesthetics (halogenated alkane derivatives)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
FC(F)OC(F)C(F)(F)F
Identifiers
PDB
CAS-ID57041-67-5
RxCUI
ChEMBL IDCHEMBL1200733
ChEBI ID4445
PubChem CID42113
DrugBankDB01189
UNII IDCRS35BZ94Q (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 9,210 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
1,266 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use